Skip to main content
. 2016 Mar 22;113(14):3885–3890. doi: 10.1073/pnas.1515895113

Fig. S7.

Fig. S7.

Tonometric IOP measurements from WT (A) and KO (B) eyes show no effect of genetic ablation or intravitreal injection of the agonist (GSK101; 75 nM) or antagonist (HC-06; 10 μM) on IOP levels at 1 d (1d PI) or 3 d (3d PI) postinjection. IOP in WT eyes was not significantly different from the IOP in KO eyes, suggesting that TRPV4 is not required for the maintenance of steady-state IOP in healthy mouse eyes.